Pharma Journalist -

Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from…
Read More...

BioNTech SE announced the acquisition of antibody assets and infrastructure from San Diego-based MabVax Therapeutics Holding, a clinical-stage oncology drug development company.…
Read More...

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib Tablets are a kinase inhibitor…
Read More...

Adimab announced the expansion of an earlier multi-target research agreement with Regeneron Pharmaceuticals. Adimab and Regeneron commenced an initial agreement in December 2014,…
Read More...

Bayer announced it will invest $150 million in its Berkeley, CA pharmaceutical development and manufacturing site to build a Cell Culture Technology Center that will be used to…
Read More...

Pfizer Inc. announced the opening of a new 175,000 square-foot manufacturing facility in Andover, Mass. Pfizer’s Andover site houses commercial manufacturing and product development…
Read More...

Armata Pharmaceuticals announced that the previously-announced merger between C3J Therapeutics, Inc. and AmpliPhi Biosciences Corporation has closed. The new combined company, known as…
Read More...

We are delighted to share three exclusive interviews with Roche, BioTekPro and Sutro Biopharma who will be speaking at the highly anticipated Pharmaceutical Microbiology West Coast…
Read More...

SMi Reports: Registration is now open for the Orphan Drugs & Rare Diseases Conference, taking place in London, UK, this October. The market for rare disease products is…
Read More...

WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation, has enrolled its first patient in the pivotal clinical study of…
Read More...